Abstract:Background: In our previous study, a mutant human acidic fibroblast growth factor without mitogenic action (nonmitogenic human acidic fibroblast growth factor) was created, and its protection from the cytotoxic effect of hydrogen peroxide treatment was confirmed in cultured cardiomyocytes. Methods: The present study was performed to further investigate whether genetically overexpressing nonmitogenic human acidic fibroblast growth factor in cardiomyocytes provides similar protection from the cytotoxic effect of hydrogen peroxide and whether in vivo administration of nonmitogenic human acidic fibroblast growth factor attenuates ischemia/reperfusion-induced cardiac dysfunction and tissue damage and protects the carotid sinus baroreceptor from alcohol-induced damage, as shown by a reduced response of blood pressure to short carotid artery occlusion. Results and conclusions: Cardiomyocytes transfected by nonmitogenic human acidic fibroblast growth factor, with significant increases in the cellular expression and secretion of nonmitogenic human acidic fibroblast growth factor into a culture medium, were resistant to hydrogen-peroxide-induced cytotoxicity, as measured by cell viability. Hearts isolated from rats pretreated with saline, human acidic fibroblast growth factor, or nonmitogenic human acidic fibroblast growth factor for 24 h were subjected to ischemia/reperfusion in the Langendorff system. Ischemia/reperfusion induced cardiac dysfunction in the saline group, but not in the group pretreated with human acidic fibroblast growth factor or nonmitogenic human acidic fibroblast growth factor. Ischemia/reperfusion also caused a release of the cardiac enzyme lactic dehydrogenase into-and an increase in lipid peroxide content in the efflux of-the hearts of saline-treated rats, but not in rats pretreated with human acidic fibroblast growth factor or nonmitogenic human acidic fibroblast growth factor. There was no difference in cardioprotective effects between human acidic fibroblast growth factor and nonmitogenic human acidic fibroblast growth factor. Furthermore, the protective effect of in-vivo-administered nonmitogenic acidic fibroblast growth factor on alcohol-induced damage to the carotid sinus baroreceptor, as shown by the reduced response of blood pressure to short carotid artery occlusion, was also observed. These results suggest that nonmitogenic human acidic fibroblast growth factor, similar to the native human acidic fibroblast growth factor, provides significant cardiovascular protection from oxidative damage in vitro and in vivo. (C) 2007 Elsevier Inc. All rights reserved.

Effect of Gilal Growth Factor on Toxic Cardiomyocytes by Adriamycin

[Adenosine Protects Cardiomyocytes from Hypoxia/reoxygenation Injury].

Effects of Fructose-1,6-diphosphate on Concentration of Calcium and Activities of Sarcoplosnic Ca2+-ATPase in Cardiomyocytes of Adriamycin-treated Rats.

Myocardial Regeneration in Adriamycin Cardiomyopathy by Nuclear Expression of GLP1 Using Ultrasound Targeted Microbubble Destruction.

[Effect of Adriamycin on Sarcoplasmic Reticulum Ca2+ -Atpase Activity in Cardiomyocyte of Rabbits]

Geniposide Alleviates Pressure Overload in Cardiac Fibrosis with Suppressed TGF-β1 Pathway

GW25-e5344 Improvement of Left Ventricular Myocardial Perfusion after Acidic Fibroblast Growth Factor Delivered by Using Ultrasound-Targeted Microbubble Destruction in Diabetic Cardiomyopathy in Rats: an Preliminary Study

Prevent Diabetic Cardiomyopathy in Diabetic Rats by Combined Therapy of Afgf-Loaded Nanoparticles and Ultrasound-Targeted Microbubble Destruction Technique.

Effect of Edaravone on Adriamycin-induced Myocardial Toxicity and Its Possible Mechanisms

The Protective effect of CGPR on cardiac function in the early-staged diabetic mice postiscbemic injury

[Protective effects of extract of Ginkgo biloba on adriamycin-induced heart failure and its mechanism: role of ghrelin peptide]

A new FGF1 variant protects against adriamycin-induced cardiotoxicity via modulating p53 activity

Cardiovascular Protection of Nonmitogenic Human Acidic Fibroblast Growth Factor from Oxidative Damage in Vitro and in Vivo

Growth differentiation factor 11 mitigates cardiac radiotoxicity via activating AMPKα

Astragaloside IV Attenuates the Myocardial Injury Caused by Adriamycin by Inhibiting Autophagy

Protective Effects of L-carnitine Against Simulated Ischemia and Reperfusion Injury in Cultured Neonatal Rat Cardiomyocytes

The protective effects of recombinant adenovirus-mediated glia cell line-derivedneurotrophic factor (GDNF) on the cultured primary spinal motoneurons

Effect of L-carnitine on Apoptosis and Oxidant Damage of Cardiomyocytes Induced by Hypoxia/reoxygenation in Vitro

Effect of hypodermic injection of granulocyte colony-stimulating factor on cardiomyocyte apoptosis and fibrosis after myocardial ischemia-reperfusion in swine

Effect of the TGFβ1-Gene Modified Dendritic Cells on the Survival of Cardiac Grafts in Rats

Cardiovascular Effect of Growth Differentiation Factor 15